DS-7309
Sponsors
Daiichi Sankyo
Conditions
Type 2 Diabetes Mellitus
Phase 1
A Two-Part, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS-7309 in Healthy Volunteers and Subjects With Type 2 Diabetes Mellitus
CompletedNCT01862939
Start: 2011-04-30End: 2011-09-30Updated: 2013-05-27
Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study
CompletedNCT01956305
Start: 2013-09-30End: 2014-06-30Updated: 2014-11-24